THYROCARE TECH LTD Intrinsic Value
THYROCARE · Healthcare · Current price ₹577.2
Is THYROCARE TECH LTD undervalued?
DocStoX estimates the fair value of THYROCARE TECH LTD at ₹317 per share, versus the current market price of ₹577. That puts the stock about -45.1% above our fair-value estimate, which we read as "Avoid". Our confidence in this estimate is low.
How this fair value is calculated
This estimate blends 4 independent methods: Residual income (₹72), Relative P/E (₹662), Graham floor (₹92), Analyst target (₹665). We weight each by its reliability and skip any method whose inputs look untrustworthy — "no DCF beats a wrong DCF". This is the same deterministic engine that powers DocStoX stock pages; there is no guesswork or AI-generated number here.
Bear, base and bull scenarios
Our scenarios span ₹72 (bear) to ₹317 (base) to ₹665 (bull). A margin of safety means buying meaningfully below the base case — the wider the gap, the more room for error in the assumptions.
Margin of safety
Value investors demand a margin of safety — a discount to intrinsic value that protects against being wrong. At ₹577 versus an intrinsic value of ₹317, THYROCARE TECH LTD currently offers -45.1% of negative margin (i.e. a premium).
More on THYROCARE TECH LTD
DocStoX estimates are generated by a deterministic valuation engine from reported financials — for informational purposes only, not investment advice. Consult a SEBI-registered advisor before investing.